4//SEC Filing
Ribas Antoni 4
Accession 0001209191-21-038639
CIK 0001724521other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:44 PM ET
Size
8.1 KB
Accession
0001209191-21-038639
Insider Transaction Report
Form 4
Ribas Antoni
Director
Transactions
- Award
Common Stock
2021-06-03+3,000→ 11,050 total - Award
Stock Option (Right to Buy)
2021-06-03+14,100→ 14,100 totalExercise: $24.79Exp: 2031-06-02→ Common Stock (14,100 underlying)
Holdings
- 8,553(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents the grant of restricted stock units that vest 100% on the earlier of June 3, 2022 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]Includes 3,000 shares of restricted stock units (previously reported) that vested on June 3, 2021.
- [F3]The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001792164
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:44 PM ET
- Size
- 8.1 KB